Clinical Trials on Alzheimer’s Disease conference (CTAD)

November 16, 2026 
- November 19, 2026

Poster Session: TRIAL DESIGN, STATISTICAL INNOVATION, AND ANALYTICAL FRAMEWORKS

Title: Plasma p-tau217 In Early Alzheimer’s Disease Trial Screening: Insights from START

Authors: Marina Ritchie1, Oliver Langford1, Yixuan Liang1, Daniel Burns2, Charlene Flournoy1, Joshua D. Grill3, Anthony Caggiano4, Michael Grundman5, Robert A. Rissman1, Paul Aisen1, Christopher H. Van Dyck6, Rema Raman1
Affiliations: 1) Alzheimer’s Therapeutic Research Institute, USC; 2) University of Kansas; 3) University of California, Irvine; 4) Cognition Therapeutics, Inc.; 5) Global R&D Partners; 6) Yale School of Medicine

Investor Relations Contact

Cognition Therapeutics
info@cogrx.com

Mikey Moyer
LifeSci Advisors
mmoyer@lifesciadvisors.com

Email Alerts

Scroll to Top

Thank you for your interest in Cognition’s publications. A PDF of the poster you are interested in will be made available in accordance with the congress’ embargo policy. Please check back soon. 

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.